Department of Biochemistry and Molecular Genetics, Hospital Clinic, Center Esther Koplowitz, August Pi i Sunyer Biomedical Research Institute, 08036 Barcelona, Spain.
J Immunol. 2011 Nov 15;187(10):5408-18. doi: 10.4049/jimmunol.1100225. Epub 2011 Oct 17.
We recently demonstrated that ω-3-polyunsaturated fatty acids ameliorate obesity-induced adipose tissue inflammation and insulin resistance. In this study, we report novel mechanisms underlying ω-3-polyunsaturated fatty acid actions on adipose tissue, adipocytes, and stromal vascular cells (SVC). Inflamed adipose tissue from high-fat diet-induced obese mice showed increased F4/80 and CD11b double-positive macrophage staining and elevated IL-6 and MCP-1 levels. Docosahexaenoic acid (DHA; 4 μg/g) did not change the total number of macrophages but significantly reduced the percentage of high CD11b/high F4/80-expressing cells in parallel with the emergence of low-expressing CD11b/F4/80 macrophages in the adipose tissue. This effect was associated with downregulation of proinflammatory adipokines in parallel with increased expression of IL-10, CD206, arginase 1, resistin-like molecule α, and chitinase-3 like protein, indicating a phenotypic switch in macrophage polarization toward an M2-like phenotype. This shift was confined to the SVC fraction, in which secretion of Th1 cytokines (IL-6, MCP-1, and TNF-α) was blocked by DHA. Notably, resolvin D1, an anti-inflammatory and proresolving mediator biosynthesized from DHA, markedly attenuated IFN-γ/LPS-induced Th1 cytokines while upregulating arginase 1 expression in a concentration-dependent manner. Resolvin D1 also stimulated nonphlogistic phagocytosis in adipose SVC macrophages by increasing both the number of macrophages containing ingested particles and the number of phagocytosed particles and by reducing macrophage reactive oxygen species production. No changes in adipocyte area and the phosphorylation of hormone-sensitive lipase, a rate-limiting enzyme regulating adipocyte lipolysis, were observed. These findings illustrate novel mechanisms through which resolvin D1 and its precursor DHA confer anti-inflammatory and proresolving actions in inflamed adipose tissue.
我们最近证明,ω-3 多不饱和脂肪酸可改善肥胖引起的脂肪组织炎症和胰岛素抵抗。在这项研究中,我们报告了 ω-3 多不饱和脂肪酸对脂肪组织、脂肪细胞和基质血管细胞(SVC)作用的新机制。高脂肪饮食诱导肥胖小鼠的炎症性脂肪组织显示出 F4/80 和 CD11b 双阳性巨噬细胞染色增加,以及 IL-6 和 MCP-1 水平升高。二十二碳六烯酸(DHA;4μg/g)并未改变巨噬细胞的总数,但显著降低了高表达 CD11b/高 F4/80 的细胞的百分比,同时在脂肪组织中出现低表达 CD11b/F4/80 的巨噬细胞。这种作用与促炎脂肪因子的下调有关,同时伴随着 IL-10、CD206、精氨酸酶 1、抵抗素样分子 α 和几丁质酶-3 样蛋白表达的增加,表明巨噬细胞向 M2 样表型的极化发生表型转换。这种转变仅限于 SVC 部分,其中 DHA 阻断了 Th1 细胞因子(IL-6、MCP-1 和 TNF-α)的分泌。值得注意的是,由 DHA 生物合成的抗炎和促分解代谢介质 resolvin D1 显著减弱了 IFN-γ/LPS 诱导的 Th1 细胞因子,同时呈浓度依赖性地上调精氨酸酶 1 的表达。Resolvin D1 还通过增加含有吞噬颗粒的巨噬细胞数量和吞噬颗粒的数量以及减少巨噬细胞活性氧的产生,刺激脂肪组织 SVC 巨噬细胞进行非炎症性吞噬作用。未观察到脂肪细胞面积和激素敏感脂肪酶(调节脂肪细胞脂肪分解的限速酶)的磷酸化发生变化。这些发现说明了 resolvin D1 和其前体 DHA 在炎症性脂肪组织中发挥抗炎和促分解代谢作用的新机制。